 |
市场调查报告书
商品编码
1550564
胃轻瘫治疗市场：按药物类别、按疾病适应症、按类型、按给药途径、按分销管道、按地区Gastroparesis Treatment Market, By Drug Class, By Disease Indication, By Type, By Route of Administration, By Distribution Channel, By Geography |
||||||
预计2024年全球胃轻瘫治疗市场规模为79.5亿美元，预计2031年将达到109.1亿美元，2024年至2031年复合年增长率为4.6%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2023年 | 2024年市场规模 | 79.5亿美元 |
| 实际资料 | 2019-2023 | 预测期 | 2024-2031 |
| 预测 2024-2031 年复合年增长率： | 4.60% | 2031年价值预测 | 109.1亿美元 |
全球胃轻瘫治疗市场的成长是由糖尿病和特发性胃轻瘫盛行率上升所推动的。胃轻瘫（排放延迟）是一种慢性疾病，胃需要很长时间才能排空其内容物。胃轻瘫患者会出现噁心、呕吐、腹胀和进食后的饱胀感。目前，胃轻瘫尚无治疗方法，可用的治疗方法主要集中在症状管理。与开发新药相关的研发活动的增加可能会推动市场成长。
市场动态：
全球胃轻瘫治疗市场的成长是由糖尿病人口增加、特发性胃轻瘫盛行率上升以及人们和医生对胃轻瘫的认识不断提高等因素所推动的。然而，患者对口服药物的依从性差、缺乏有效的治疗方法以及药物治疗的副作用可能会阻碍市场的成长。开拓疗效较好、副作用较少的新药可能为市场提供利润丰厚的成长机会。
本研究的主要特点
该报告对全球胃轻瘫治疗市场进行了详细分析，并以2023年为基准年估计了预测期内（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。 。
它还强调了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
根据公司亮点、产品系列、主要亮点、绩效和策略等参数，对全球胃轻瘫治疗市场的主要企业进行概况分析。
研究涵盖的主要企业包括雅培实验室、美敦力、迈兰、辉瑞、强生服务、Bausch Health、Antrotrans、Alembic Pharmaceuticals 等。
该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
全球胃轻瘫治疗市场报告迎合了该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过用于分析全球胃轻瘫治疗市场的各种策略矩阵来促进他们的决策。
目录
第一章 研究目的与前提
- 研究目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
第三章市场动态、法规及趋势分析
- 市场动态
- 影响分析
- 主要亮点
- 监管场景
- 产品发布/核准
- PEST分析
- 波特分析
- 併购场景
第四章全球胃轻瘫治疗市场，依药物类别，2019-2031（十亿美元）
- 胃肠蠕动促进剂
- 止吐药
- 质子帮浦抑制剂
- 其他（肉毒桿菌注射等）
第五章全球胃轻瘫治疗市场，依疾病适应症，2019-2031（十亿美元）
- 糖尿病性胃轻瘫
- 特发性胃轻瘫
- 术后胃轻瘫
第六章 2019-2031 年全球胃轻瘫治疗市场（按类型）（十亿美元）
- 非处方药
- 处方药
第七章 全球胃轻瘫治疗市场，依给药途径，2019-2031 年（十亿美元）
- 口服
- 注射
- 鼻腔
第八章全球胃轻瘫治疗市场，按分销管道，2019-2031（十亿美元）
- 医院药房
- 零售药房
- 网路药房
第九章全球胃轻瘫治疗市场，按地区，2019-2031（十亿美元）
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
第10章竞争格局
- Evoke Pharma, Inc.
- Processa Pharmaceuticals, Inc.
- Neurogastrx, Inc.
- Vanda Pharmaceuticals Inc.
- ANI Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company Limited
- GlaxoSmithKline plc
- Otsuka Holdings Co., Ltd.
- CinDome Pharma, Inc.
- PTC Therapeutics
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Atlantic Healthcare
- Salix Pharmaceuticals
- Rhythm Pharmaceuticals, Inc.
- Ironwood Pharmaceuticals, Inc.
- Medtronic plc
- Bausch Health Companies Inc.
- Sanofi SA
第十一章分析师建议
第十二章参考文献与调查方法
- 参考
- 调查方法
- 关于出版商
Global gastroparesis treatment market is estimated to be valued at USD 7.95 Bn in 2024 and is expected to reach USD 10.91 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 4.6% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 7.95 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 4.60% | 2031 Value Projection: | US$ 10.91 Bn |
Global gastroparesis treatment market growth is driven by rising prevalence of diabetes and idiopathic gastroparesis. Gastroparesis, or delayed stomach emptying, is a chronic disorder, in which the stomach takes too long to empty its contents. Patients suffering from gastroparesis experience nausea, vomiting, bloating and fullness after eating. Currently, there is no cure for gastroparesis and the available treatment options focus on managing the symptoms. Rising research and development activities related to new drug development can drive the market growth.
Market Dynamics:
Global gastroparesis treatment market growth is driven by factors such as increasing diabetic population, rising prevalence of idiopathic gastroparesis, growing awareness about gastroparesis among people and physicians. However, poor patient compliance associated with oral medication, non-availability of effective treatment and side effects of drug therapies can hamper the market growth. Development of novel drugs with better efficacy and less side effects can offer lucrative growth opportunities in the market.
Key features of the study:
This report provides in-depth analysis of the global gastroparesis treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global gastroparesis treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abbott Laboratories, Medtronic, Mylan, Pfizer, Johnson & Johnson Services, Bausch Health, Antrotrans, Alembic Pharmaceuticals
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global gastroparesis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gastroparesis treatment market
Detailed Segmentation-
- Drug Class Insights (Revenue, USD Bn, 2019 - 2031)
- Prokinetic Agents
- Antiemetic Drugs
- Proton Pump Inhibitors
- Others (Botulinum Toxin Injections, etc.)
- Disease Indication Insights (Revenue, USD Bn, 2019 - 2031)
- Diabetes Gastroparesis
- Idiopathic Gastroparesis
- Post-surgical Gastroparesis
- Type Insights (Revenue, USD Bn, 2019 - 2031)
- Over-the-Counter Drugs
- Prescription Drugs
- Route of Administration Insights (Revenue, USD Bn, 2019 - 2031)
- Oral
- Injectables
- Nasal
- Distribution Channel Insights (Revenue, USD Bn, 2019 - 2031)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Evoke Pharma, Inc.
- Processa Pharmaceuticals, Inc.
- Neurogastrx, Inc.
- Vanda Pharmaceuticals Inc.
- ANI Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company Limited
- GlaxoSmithKline plc
- Otsuka Holdings Co., Ltd.
- CinDome Pharma, Inc.
- PTC Therapeutics
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Atlantic Healthcare
- Salix Pharmaceuticals
- Rhythm Pharmaceuticals, Inc.
- Ironwood Pharmaceuticals, Inc.
- Medtronic plc
- Bausch Health Companies Inc.
- Sanofi S.A.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Gastroparesis Treatment Market, By Drug Class
- Global Gastroparesis Treatment Market, By Disease Indication
- Global Gastroparesis Treatment Market, By Type
- Global Gastroparesis Treatment Market, By Route of Administration
- Global Gastroparesis Treatment Market, By Distribution Channel
- Global Gastroparesis Treatment Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Gastroparesis Treatment Market, By Drug Class, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Prokinetic Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Antiemetic Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Proton Pump Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others (Botulinum Toxin Injections, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Global Gastroparesis Treatment Market, By Disease Indication, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Diabetes Gastroparesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Idiopathic Gastroparesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Post-surgical Gastroparesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Gastroparesis Treatment Market, By Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends
- Over-the-Counter Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Prescription Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Gastroparesis Treatment Market, By Route of Administration, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Injectables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Nasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Gastroparesis Treatment Market, By Distribution Channel, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
9. Global Gastroparesis Treatment Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020- 2031, e (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country/Sub-region, 2019 - 2031, (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Evoke Pharma, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Processa Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Neurogastrx, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vanda Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ANI Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GlaxoSmithKline plc
- Otsuka Holdings Co., Ltd.
- CinDome Pharma, Inc.
- PTC Therapeutics
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Atlantic Healthcare
- Salix Pharmaceuticals
- Rhythm Pharmaceuticals, Inc.
- Ironwood Pharmaceuticals, Inc.
- Medtronic plc
- Bausch Health Companies Inc.
- Sanofi S.A.
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
